Gene and cell therapy using cell fusion technology
US-11998617-B2 · Jun 4, 2024 · US
Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
US8940293B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8940293-B2 |
| Application number | US-201113091028-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 20, 2011 |
| Priority date | May 14, 1999 |
| Publication date | Jan 27, 2015 |
| Grant date | Jan 27, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a treatment of an autoimmune demyelinating disease/disorder. Also included in the present invention is the use of bone marrow stromal cells for the treatment of multiple sclerosis (MS).
First claim
Opening claim text (preview).
What is claimed: 1. A method of treating a mammal having a disease, disorder or condition of the central nervous system, the method comprising isolating a stromal cell from a bone marrow sample, culturing the cells in the presence of a growth factor selected from the group consisting of NGF, BDNF and EGF, and administering by intravascular administration adjacent to the lesion said stromal cell to said mammal, wherein the cells are not fully differentiated prior to administration a…
Assignees
Inventors
Classifications
- A61K35/30Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K38/185Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8940293B2 cover?
- The present invention relates to a treatment of an autoimmune demyelinating disease/disorder. Also included in the present invention is the use of bone marrow stromal cells for the treatment of multiple sclerosis (MS).
- Who is the assignee on this patent?
- Li Yi, Chopp Michael, Ford Henry Health System
- What technology area does this patent fall under?
- Primary CPC classification A61K35/30. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).